Megan Smith
Adult Health · Orlando, FLNPI 1689998353
Payments from drug & device makers
Across 61 payments — averaging $70.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$551
- Johnson & Johnson$445
- Novartis$417
- Amgen$360
- Sanofi$331
- Jazz Pharmaceuticals Inc.$249
- plus $2K from 20 others
What the payments were for
- Food & beverage$4,22798%
- Education$702%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 6 | $551 |
| Johnson & Johnson | 5 | $445 |
| Novartis | 7 | $417 |
| Amgen | 3 | $360 |
| Sanofi | 3 | $331 |
| Jazz Pharmaceuticals Inc. | 2 | $249 |
| E.r. Squibb & Sons, L.L.C. | 2 | $248 |
| Astellas Pharma US Inc | 5 | $229 |
| Incyte Corporation | 4 | $198 |
| GSK | 3 | $156 |
| Iovance Biotherapeutics, Inc. | 1 | $142 |
| Bristol Myers Squibb | 1 | $125 |
| Rigel Pharmaceuticals, Inc. | 1 | $118 |
| La Jolla Pharmaceutical Company | 1 | $112 |
| Shionogi Inc | 1 | $100 |
| Adaptive Biotechnologies Corporation | 1 | $97 |
| Stemline Therapeutics Inc. | 1 | $92 |
| Sanofi-aventis U.S. LLC | 4 | $89 |
| Autolus Inc | 2 | $45 |
| Beigene USA, Inc. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
| Legend Biotech USA Inc. | 1 | $31 |
| Medline Industries LP | 1 | $31 |
| Mallinckrodt Hospital Products Inc. | 1 | $22 |
| Pfizer | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,297 in reported general payments places this provider in the 85th percentile of 2,237 adult health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PrevymisLetermovir | 13 | $95,606 |
Paid to pharmacies, not to this prescriber.
Other adult health in Orlando
- Sita SwamyOrlando$49K
- Alejandro Dela CruzOrlando$44K
- Andreina NeallOrlando$16K
- Jessica SettineriOrlando$14K
- Kristen KessingerOrlando$13K
- Angelo LewisOrlando$12K
- Patricia PagnottaMaitland$441K
- Carly KoelschSarasota$265K
- Norma SolisMiami$150K
- Ashley PontenbergWinter Park$136K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.